![]() |
市場調查報告書
商品編碼
1465117
女性骨盆腔植入市場:按產品類型、適應症和最終用戶分類 - 全球預測 2024-2030Female Pelvic Implants Market by Product Type (Vaginal Graft Implants, Vaginal Mesh Implants, Vaginal Sling), Indication (Pelvic Organ Prolapse, Stress Urinary Incontinence), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年女性骨盆腔植入市場規模為9.7232億美元,2024年將達10.1559億美元,2030年將達到13.4729億美元,複合年成長率為4.76%。
女性骨盆腔植入是一種專用設計用於治療骨盆底疾病的醫療設備,包括骨盆器官脫垂(POP)和壓力性尿失禁(SUI)。這些情況通常是由分娩、手術或老齡化引起的,並影響骨盆底的結構和強度。透過手術插入含有合成網或生物材料的植入,以支撐骨盆器官,包括膀胱、子宮和腸道,並修復或強化受損或衰弱的骨盆底肌肉和組織。隨著全世界女性骨盆底疾病的增加,對骨盆腔植入的需求也增加。醫療基礎設施的改善和對骨盆底疾病意識的提高正在促進女性用骨盆植入市場的成長。然而,監管挑戰和過去有關網狀植入安全性的訴訟極大地限制了市場的成長。此外,缺乏訓練有素的外科醫生來有效地進行骨盆植入手術,限制了女性可用的治療選擇,包括網狀糜爛、感染和植入排斥併發症,導致患者不適和需要再次手術。然而,對更安全、更俱生物相容性的材料的持續研究可以減少併發症並改善患者的治療結果,從而提供顯著的成長機會。微創手術技術的開拓可能會提高患者的接受度並擴大骨盆腔植入市場。
主要市場統計 | |
---|---|
基準年[2023] | 97232萬美元 |
預測年份 [2024] | 1,015,590,000 美元 |
預測年份 [2030] | 1,347.29 百萬美元 |
複合年成長率(%) | 4.76% |
產品類型:由於有效治療壓力性尿失禁,陰道吊帶的使用範圍擴大
陰道移植植入是用於治療和控制骨盆器官脫垂(POP) 和壓力性尿失禁的手術裝置。這些植入旨在為虛弱的骨盆底肌肉和器官提供額外的支撐。它們可以由聚丙烯之類的合成材料製成,或由自體(來自患者自己的身體)、異種(來自不同物種)或同種異體(來自相同物種)的生物材料製成。陰道移植植入的主要目的是恢復正常的骨盆底功能和解剖結構,並提高患者的生活品質。陰道網狀植入是陰道植入的子集,由合成的、不可吸收的網狀材料專門製成。它常用於骨盆器官脫垂和壓力性尿失禁等疾病的手術治療。這些植入旨在永久強化骨盆底薄弱的結構。陰道吊帶是一種外科手術,利用一條合成網或生物材料在尿道周圍形成支撐吊帶。手術的具體目的是為尿道提供額外的支撐,以防止運動、咳嗽或打噴嚏時發生的不自覺尿液漏出。陰道吊帶因其有效性而受到高度讚揚,並已成為患有壓力性尿失禁的女性廣泛接受的手術選擇。
最終用戶:擁有完善設施和廣泛專家的醫院擴大採用女性骨盆植入。
門診手術中心 (ASC) 是現代化的醫療機構,提供當天的手術護理,包括診斷和預防解決方案及程序。 ASC 以其效率和成本效益而聞名。 ASC 為進行小型手術(包括女性骨盆腔植入)提供了便利且安全的環境。醫院是使用女性骨盆腔植入的主要場所。醫院擁有更全面的基礎設施和更廣泛的專家,可以處理骨盆器官脫垂和失禁的複雜病例。醫院配備了先進的醫療解決方案和醫療設備,以及出色的術後護理,使其成為包括骨盆植入在內的複雜手術干預的最合適環境。我們的多學科團隊和加護病房進一步支持了我們在骨盆腔植入應用方面的主導地位。專科診所專注於特定的醫學領域或特定的服務,例如治療骨盆底疾病的泌尿生殖醫學。這些診所提供有針對性的治療,並經常聘請在女性骨盆健康方面擁有深厚專業知識的專家。儘管專科診所在需要骨盆腔植入的疾病的診斷和初步管理中發揮重要作用,但它們在實際植入手術中的作用可能會受到設施手術能力的限制。
區域洞察
由於人口老化、強大且高度發達的醫療基礎設施以及人們對骨盆健康問題的認知不斷提高,美洲,特別是美國和加拿大對女性骨盆植入的需求很高。美國的研究活動非常活躍,由學術機構和工業界共同主導。美洲最近的專利展示了植入材料和微創應用技術的創新。包括中國、日本、印度等在內的亞太地區女性用骨盆腔植入市場正在快速成長。這一成長的推動因素包括醫療費用的上漲、對骨盆疾病的認知提高以及醫療基礎設施的改善。日本以其先進的研究和高技術採用率而脫穎而出。中國和印度由於人口眾多且獲得醫療服務的機會不斷增加,正在成為重要的市場。該地區對當地製造和研究項目進行了大量投資。歐盟國家受益於先進的醫療保健系統和對骨盆健康問題的廣泛認知,促進了創新骨盆植入的開發。歐盟的研究和發展得到大學、醫院和公司之間的津貼和合作的支持。管理醫療產品製造和性能的多項嚴格法規的存在,為女性骨盆植入的發展創建了高度標準化的框架。
FPNV定位矩陣
FPNV定位矩陣對於評估女性骨盆腔植入市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對女性骨盆植入市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.女性骨盆腔植入市場規模及預測為何?
2.女性骨盆植入市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.女性骨盆腔植入市場的技術趨勢和法規結構是什麼?
4.女性骨盆腔植入市場主要廠商的市場佔有率為何?
5.進入女性骨盆腔植入市場的合適形式和策略手段是什麼?
[197 Pages Report] The Female Pelvic Implants Market size was estimated at USD 972.32 million in 2023 and expected to reach USD 1,015.59 million in 2024, at a CAGR 4.76% to reach USD 1,347.29 million by 2030.
Female pelvic implants are medical devices designed specifically for the treatment of pelvic floor disorders, including pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These conditions are often caused by childbirth, surgery, or aging, affecting the pelvic floor's structure and strength. The implants, which include synthetic mesh or biological materials, are surgically inserted to support the pelvic organs, including the bladder, uterus, and bowel, and to repair or reinforce the damaged or weakened pelvic floor muscles and tissues. The rising cases of pelvic floor disorders among women globally create a need for pelvic implants. Improved healthcare infrastructure and heightened awareness about pelvic floor disorders have contributed to the growth of the female pelvic implant market. However, regulatory challenges and historical lawsuits related to safety concerns of mesh implants pose considerable restraints on market growth. Moreover, the shortage of adequately trained surgeons to perform pelvic implant surgeries effectively limits the treatment options available to women, and complications such as mesh erosion, infection, and implant rejection have been reported, leading to patient discomfort and the need for revision surgeries. However, continued research into safer, more biocompatible materials can reduce complications and improve patient outcomes, presenting significant growth opportunities. The development of less invasive surgical techniques would likely increase patient acceptance and widen the market for pelvic implants.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 972.32 million |
Estimated Year [2024] | USD 1,015.59 million |
Forecast Year [2030] | USD 1,347.29 million |
CAGR (%) | 4.76% |
Product Type: Expanding usage of vaginal sling due to its efficacy in treating stress urinary incontinence
Vaginal graft implants are surgical devices used in the treatment and management of pelvic organ prolapse (POP) and stress urinary incontinence. These implants are designed to provide additional support to the weakened pelvic floor muscles and organs. They can be made from synthetic materials, such as polypropylene, or biological materials, which can be either autologous (from the patient's own body), heterologous (from a different species), or allogeneic (from the same species). The primary goal of vaginal graft implants is to restore normal pelvic floor function and anatomy, thereby improving the patient's quality of life. Vaginal mesh implants are a subset of vaginal graft implants specifically constructed from synthetic, non-absorbable mesh. They are commonly used for the surgical treatment of conditions, including pelvic organ prolapse and stress urinary incontinence. These implants are designed to provide a permanent reinforcement to the weakened structures of the pelvic floor. The vaginal sling is a surgical procedure that utilizes a strip of synthetic mesh or biological material to create a supportive sling around the urethra. This procedure is specifically aimed at preventing involuntary urine leakage that occurs during physical activities, coughing, or sneezing by providing additional support to the urethra. Vaginal slings are highly regarded for their efficacy and have become a widely accepted surgical option for women suffering from stress urinary incontinence.
End User: Emerging adoption of female pelvic implants by hospitals owing to their comprehensive facilities and wide range of specialists
Ambulatory surgical centers (ASCs) are modern healthcare structures that provide same-day surgical care, including diagnostic and preventive solutions and procedures. ASCs are known for their efficiency and cost-effectiveness. They offer a convenient and safe environment for the performance of minor surgeries, including those involving female pelvic implants. Hospitals are the primary setting for the use of female pelvic implants. They have a more comprehensive infrastructure and a broader range of specialists to manage complex cases of pelvic organ prolapse and incontinence. Hospitals are equipped with advanced medical solutions and equipment and offer extensive postoperative care, making them the most suitable environment for complex surgical interventions involving pelvic implants. The availability of multi-disciplinary teams and intensive care units further supports their leading position in the application of these implants. Specialty clinics focus on particular fields of medicine or specific services, including urogynecology, which involves the treatment of pelvic floor disorders. These clinics provide targeted care and often employ specialists with deep expertise in female pelvic health. While specialty clinics play a crucial role in the diagnosis and initial management of conditions necessitating pelvic implants, their role in the actual implantation procedures may be limited by the surgical capacity of the facility.
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high need for female pelvic implants due to aging populations, robust and highly developed healthcare infrastructure, and increasing awareness of pelvic health issues. The U.S. exhibits robust research activities led by both academic institutions and industry players. Recent patents in the Americas region demonstrate innovations in implant materials and minimally invasive application techniques. The Asia Pacific region, including China, Japan, India, and other countries, is witnessing rapid growth in the female pelvic implant market. This growth is spurred by increasing healthcare expenditures, rising awareness of pelvic disorders, and improving healthcare infrastructure. Japan stands out for its advanced research and a high rate of technology adoption. China and India are emerging as significant markets due to their large populations and increasing access to healthcare services. Investments in local manufacturing and research initiatives are prominent in this region. European Union countries benefit from advanced healthcare systems and widespread awareness of pelvic health issues, driving the development of innovative pelvic implants. Research and development in the EU are supported by grants and collaborations among universities, hospitals, and companies. The presence of several stringent regulations governing the manufacture and performance of medical products creates a highly standardized framework for the progress of female pelvic implants.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Female Pelvic Implants Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Female Pelvic Implants Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Female Pelvic Implants Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, B. Braun of America Inc., Betatech Medical, Boston Scientific Corporation, Caldera Medical, CARDIOLINK S.L. by CB Scientific, Inc., Coloplast Corp., Cook Group Incorporated, CurvaFix, Inc., Medtronic, Narang Medical Limited, Neomedic Int, Olympus Corporation, PALEX MEDICAL, S.A, pfm Medical GmbH, PROMEDON GmbH, SARS Cousin Biotech, Tecomet, Inc., Zimmer Biomet, and ZSI Surgical Implants S.R.L..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Female Pelvic Implants Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Female Pelvic Implants Market?
3. What are the technology trends and regulatory frameworks in the Female Pelvic Implants Market?
4. What is the market share of the leading vendors in the Female Pelvic Implants Market?
5. Which modes and strategic moves are suitable for entering the Female Pelvic Implants Market?